These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 27053851)
41. FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients. Ryan M; Crow J; Kahmke R; Fisher SR; Su Z; Lee WT Am J Otolaryngol; 2014; 35(6):689-94. PubMed ID: 25212103 [TBL] [Abstract][Full Text] [Related]
42. Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1. Botticelli A; Mezi S; Pomati G; Cerbelli B; Cerbelli E; Roberto M; Giusti R; Cortellini A; Lionetto L; Scagnoli S; Zizzari IG; Nuti M; Simmaco M; Marchetti P Front Immunol; 2020; 11():1243. PubMed ID: 32733441 [No Abstract] [Full Text] [Related]
43. Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival. Ferns DM; Kema IP; Buist MR; Nijman HW; Kenter GG; Jordanova ES Oncoimmunology; 2015 Feb; 4(2):e981457. PubMed ID: 25949879 [TBL] [Abstract][Full Text] [Related]
44. Determination of kynurnine and tryptophan, biomarkers of indoleamine 2,3-dioxygenase by LC-MS/MS in plasma and tumor. Wang W; Zhuang X; Liu W; Dong L; Sun H; Du G; Ye L Bioanalysis; 2018 Aug; 10(16):1335-1344. PubMed ID: 30130131 [TBL] [Abstract][Full Text] [Related]
45. Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? Botticelli A; Cerbelli B; Lionetto L; Zizzari I; Salati M; Pisano A; Federica M; Simmaco M; Nuti M; Marchetti P J Transl Med; 2018 Aug; 16(1):219. PubMed ID: 30081936 [TBL] [Abstract][Full Text] [Related]
46. Early Posttransplant Tryptophan Metabolism Predicts Long-term Outcome of Human Kidney Transplantation. Vavrincova-Yaghi D; Seelen MA; Kema IP; Deelman LE; van der Heuvel MC; Breukelman H; Van den Eynde BJ; Henning RH; van Goor H; Sandovici M Transplantation; 2015 Aug; 99(8):e97-104. PubMed ID: 25651307 [TBL] [Abstract][Full Text] [Related]
47. Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Changsirivathanathamrong D; Wang Y; Rajbhandari D; Maghzal GJ; Mak WM; Woolfe C; Duflou J; Gebski V; dos Remedios CG; Celermajer DS; Stocker R Crit Care Med; 2011 Dec; 39(12):2678-83. PubMed ID: 21765346 [TBL] [Abstract][Full Text] [Related]
48. Metastatic potential in T1 and T2 colorectal cancer. Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758 [TBL] [Abstract][Full Text] [Related]
49. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers. Sperner-Unterweger B; Neurauter G; Klieber M; Kurz K; Meraner V; Zeimet A; Fuchs D Immunobiology; 2011 Mar; 216(3):296-301. PubMed ID: 20822828 [TBL] [Abstract][Full Text] [Related]
50. Clinical significance of tryptophan catabolism in follicular lymphoma. Masaki A; Ishida T; Maeda Y; Ito A; Suzuki S; Narita T; Kinoshita S; Yoshida T; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Choi I; Suehiro Y; Iida S Hematol Oncol; 2020 Dec; 38(5):742-753. PubMed ID: 32940915 [TBL] [Abstract][Full Text] [Related]
51. Assessment of neopterin and indoleamine 2,3-dioxygenase activity in patients with seasonal influenza: A pilot study. Pizzini A; Kurz K; Santifaller J; Tschurtschenthaler C; Theurl I; Fuchs D; Weiss G; Bellmann-Weiler R Influenza Other Respir Viruses; 2019 Nov; 13(6):603-609. PubMed ID: 31489989 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients. Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910 [TBL] [Abstract][Full Text] [Related]
54. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Okuyama T; Oya M; Ishikawa H Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212 [TBL] [Abstract][Full Text] [Related]
55. [Indoleamine 2, 3-dioxygenase activity during neoadjuvant chemotherapy in patients with breast cancer]. Sakurai K; Fujisaki S; Nagashima S; Maeda T; Tomita R; Suzuki S; Hara Y; Hirano T; Enomoto K; Amano S Gan To Kagaku Ryoho; 2013 Nov; 40(12):1578-80. PubMed ID: 24393854 [TBL] [Abstract][Full Text] [Related]
56. Indoleamine 2,3-dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival. Souissi S; Ghedira R; Macherki Y; Ben-Haj-Ayed A; Gabbouj S; Remadi Y; Sfar I; Chadli Z; Aouam K; Hassine M; Bouaouina N; Zakhama A; Hassen E Immun Inflamm Dis; 2022 Sep; 10(9):e690. PubMed ID: 36039641 [TBL] [Abstract][Full Text] [Related]
57. Activation of the kynurenine pathway is associated with poor outcome in Pneumocystis pneumonia patients infected with HIV: results of 2 months cohort study. Wang M; Dong X; Huang Y; Su J; Dai X; Guo Y; Hu C; Zhou Q; Zhu B BMC Infect Dis; 2019 Mar; 19(1):223. PubMed ID: 30832615 [TBL] [Abstract][Full Text] [Related]
58. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma. Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066 [TBL] [Abstract][Full Text] [Related]
59. Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season. Pertovaara M; Hasan T; Raitala A; Oja SS; Yli-Kerttula U; Korpela M; Hurme M Clin Exp Immunol; 2007 Nov; 150(2):274-8. PubMed ID: 17711489 [TBL] [Abstract][Full Text] [Related]
60. [Indoleamine 2,3-Dioxygenase Activity in Intracystic Breast Tumors]. Sakurai K; Fujisaki S; Adachi K; Suzuki S; Masuo Y; Nagashima S; Hara Y; Enomoto K; Hirano T; Tomita R; Gonda K Gan To Kagaku Ryoho; 2016 Oct; 43(10):1295-1297. PubMed ID: 27760965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]